Detection of atrial fibrillation in persons aged 65 years and above using a mobile electrocardiogram device.

Autor: Daniëls F; Department of Cardiology, Isala Heart Centre, Zwolle, The Netherlands. f.daniels@isala.nl., Ramdjan TTTK; Department of Cardiology, Isala Heart Centre, Zwolle, The Netherlands., Mánfai B; Department of Cardiology, Isala Heart Centre, Zwolle, The Netherlands., Adiyaman A; Department of Cardiology, Isala Heart Centre, Zwolle, The Netherlands., Smit JJJ; Department of Cardiology, Isala Heart Centre, Zwolle, The Netherlands., Delnoy PPHM; Department of Cardiology, Isala Heart Centre, Zwolle, The Netherlands., Elvan A; Department of Cardiology, Isala Heart Centre, Zwolle, The Netherlands.
Jazyk: angličtina
Zdroj: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation [Neth Heart J] 2024 Apr; Vol. 32 (4), pp. 160-166. Date of Electronic Publication: 2023 Nov 28.
DOI: 10.1007/s12471-023-01828-6
Abstrakt: Background: Untreated atrial fibrillation (AF) often results in increased morbidity and mortality. Opportunistic AF screening in persons aged ≥ 65 years is recommended to identify patients with AF in order to prevent AF-related complications.
Objective: The aim of this study was to assess the feasibility of screening persons for AF with the Kardia mobile electrocardiogram device (MED) and to determine the percentage of newly detected AF cases by selective population screening in the Netherlands.
Methods: Persons aged ≥ 65 years, without a medical history of AF, in nursing homes, at public events or visiting the general practitioner (GP) were approached to participate. A Kardia MED smartphone ECG (sECG) was recorded and the CHA 2 DS 2 -VASc score was calculated. An automated AF algorithm classified the sECGs as 'sinus rhythm', 'AF' or 'unclassified'. In the case of AF, participants were referred to their GP. All sECGs were assessed by blinded experts.
Results: A total of 2168 participants were screened for AF. According to the expert's interpretation, 2.5% had newly detected AF, of whom 76.4% never experienced palpitations and 89.1% had a CHA 2 DS 2 -VASc score ≥ 2. The algorithm result was unclassified in 12.2% of cases, of which 95.5% were interpretable by experts. With expert opinion as the gold standard and excluding unclassified sECGs, the Kardia MED's negative and positive predictive value for detecting AF was 99.8% and 60.0%, respectively.
Conclusion: Screening for AF using the Kardia MED is feasible and results in 2.5% newly detected AF cases. Expert interpretation of algorithm outcomes AF and unclassified is recommended.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: